Equifax (EFX) Competitors $257.15 +0.90 (+0.35%) Closing price 09/15/2025 03:59 PM EasternExtended Trading$256.77 -0.38 (-0.15%) As of 09/15/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EFX vs. CCRN, CRAI, FI, G, IQV, IT, OMC, RHI, TRU, and WMShould you be buying Equifax stock or one of its competitors? The main competitors of Equifax include Cross Country Healthcare (CCRN), Charles River Associates (CRAI), Fiserv (FI), Genpact (G), IQVIA (IQV), Gartner (IT), Omnicom Group (OMC), Robert Half (RHI), TransUnion (TRU), and Waste Management (WM). Equifax vs. Its Competitors Cross Country Healthcare Charles River Associates Fiserv Genpact IQVIA Gartner Omnicom Group Robert Half TransUnion Waste Management Equifax (NYSE:EFX) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Does the media refer more to EFX or CCRN? In the previous week, Equifax had 18 more articles in the media than Cross Country Healthcare. MarketBeat recorded 22 mentions for Equifax and 4 mentions for Cross Country Healthcare. Equifax's average media sentiment score of 1.37 beat Cross Country Healthcare's score of 1.23 indicating that Equifax is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Equifax 18 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cross Country Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, EFX or CCRN? Equifax has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEquifax$5.68B5.60$604.10M$5.1150.32Cross Country Healthcare$1.34B0.32-$14.56M-$0.26-50.62 Is EFX or CCRN more profitable? Equifax has a net margin of 10.95% compared to Cross Country Healthcare's net margin of -0.70%. Equifax's return on equity of 18.89% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Equifax10.95% 18.89% 7.84% Cross Country Healthcare -0.70%1.72%1.24% Which has more risk & volatility, EFX or CCRN? Equifax has a beta of 1.68, meaning that its stock price is 68% more volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. Do institutionals & insiders believe in EFX or CCRN? 96.2% of Equifax shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 1.4% of Equifax shares are held by company insiders. Comparatively, 4.9% of Cross Country Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts prefer EFX or CCRN? Equifax currently has a consensus price target of $284.80, indicating a potential upside of 10.75%. Cross Country Healthcare has a consensus price target of $17.93, indicating a potential upside of 36.25%. Given Cross Country Healthcare's higher possible upside, analysts clearly believe Cross Country Healthcare is more favorable than Equifax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Equifax 0 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.74Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryEquifax beats Cross Country Healthcare on 15 of the 17 factors compared between the two stocks. Get Equifax News Delivered to You Automatically Sign up to receive the latest news and ratings for EFX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EFX vs. The Competition Export to ExcelMetricEquifaxConsulting IndustryBusiness SectorNYSE ExchangeMarket Cap$31.72B$6.77B$26.43B$21.53BDividend Yield0.78%1.70%2.75%3.50%P/E Ratio50.3223.4026.9729.84Price / Sales5.602.97816.8971.01Price / Cash19.9716.6525.8718.13Price / Book6.625.517.704.65Net Income$604.10M$272.15M$199.11M$999.94M7 Day Performance1.95%3.21%3.48%1.08%1 Month Performance3.80%4.43%20.19%4.53%1 Year Performance-15.44%-8.18%49.63%14.39% Equifax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EFXEquifax4.8749 of 5 stars$257.15+0.4%$284.80+10.8%-16.2%$31.72B$5.68B50.3214,700Positive NewsAnalyst ForecastCCRNCross Country Healthcare3.5901 of 5 stars$14.05-0.4%$17.93+27.6%-7.1%$461.94M$1.19B-54.048,205Positive NewsCRAICharles River Associates2.9092 of 5 stars$192.90-0.7%$228.00+18.2%+22.8%$1.27B$687.41M23.35940FIFiserv4.9221 of 5 stars$135.030.0%$207.36+53.6%-24.1%$73.40B$20.46B22.5438,000GGenpact4.3104 of 5 stars$44.26-1.4%$52.29+18.1%+7.2%$7.71B$4.77B14.70140,000Insider TradeIQVIQVIA4.9424 of 5 stars$187.72+0.0%$229.86+22.4%-22.0%$31.91B$15.41B27.1788,000Positive NewsITGartner4.9452 of 5 stars$245.860.0%$369.25+50.2%-51.6%$18.62B$6.30B15.1321,044OMCOmnicom Group4.8884 of 5 stars$79.00-0.5%$94.43+19.5%-23.1%$15.30B$15.69B11.3374,900Positive NewsRHIRobert Half4.8917 of 5 stars$35.94-3.0%$45.83+27.5%-44.6%$3.66B$5.80B20.5414,700TRUTransUnion4.8587 of 5 stars$93.67+4.0%$112.64+20.3%-11.0%$18.25B$4.18B46.8313,400Positive NewsHigh Trading VolumeWMWaste Management4.794 of 5 stars$219.03-0.5%$254.35+16.1%+3.9%$88.23B$23.95B32.5061,700Ex-Dividend Related Companies and Tools Related Companies Cross Country Healthcare Alternatives Charles River Associates Alternatives Fiserv Alternatives Genpact Alternatives IQVIA Alternatives Gartner Alternatives Omnicom Group Alternatives Robert Half Alternatives TransUnion Alternatives Waste Management Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EFX) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe End of Elon Musk…?Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredAmerica’s most terrifying chart?MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equifax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Equifax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EFX Stock Alerts